Results · Jul-Sep 2026 · filed 17 Oct 2026
Hemo Organic Q2 FY27 results
Sales grew 1428900% to ₹1.4 crore from ₹0 crore in Jul-Sep 2025.
Operating profit was ₹0.01 crore, an operating margin of 0.4% (up 41000.4 points from a year ago).
Net profit turned positive: ₹0.01 crore against a loss of ₹0.03 crore in Jul-Sep 2025.
Against Apr-Jun 2026: net profit turns positive.
Jul-Sep 2026 vs a year ago
| ₹ crore | Jul-Sep 2026 | Jul-Sep 2025 | Change |
|---|---|---|---|
| Sales | 1.4 | 0.0 | +1428900% |
| Operating profit (EBITDA) | 0.0 | -0.0 | n/m |
| Operating margin | 0.4% | −41000.0% | +41000.4 pts |
| Net profit | 0.0 | -0.0 | turns positive |
Standalone figures. Margins & ratios change in percentage points (pts).
The last 8 quarters
Filings that week
- 19 Oct 2026Announcement under Regulation 30 (LODR)-Newspaper Publication
- 17 Oct 2026Statement On Deviation(S) / Variation(S) In Utilization Of Proceeds Raised Through Preferential Issue Of Convertible Warrants, Pursuant To Regulation 32 Of SEBI
- 17 Oct 2026Submission Of Un-Audited Financial Results Along With Limited Review Report Thereon For The Quarter And Half Year Ended 30Th September, 2026
- 17 Oct 2026Board Meeting Outcome for The Meeting Held Today I.E., Saturday, 17Th October, 2026
- 14 Oct 2026Board Meeting Intimation for The Meeting To Be Held On Saturday, I.E., 17Th October, 2026
- 14 Oct 2026Withdrawal Of Consent To Act As Company Secretary And Compliance Officer
From the company's results filed on BSE (Standalone). Business numbers only. Education & analysis, not investment advice or a recommendation.